
AgenusDeveloper of a gene and cell therapy company focused on developing life changing treatments for serious diseases. The company's platform builds exclusive cutting-edge technologies and capabilities, based on a sector leading and proprietary single dose gene therapy platform LentiVector with which they design, develop and produce gene and cell based medicines for themselves and their partners in the areas of oncology, ophthalmology and CNS disorders.

Tell Oxford BioMedica you're interested in working at the company, while keeping your personal identity anonymous. Comparably will give Oxford BioMedica the opportunity to hire you. When there's a job opening that's a fit we'll make the match happen.
Send them an invite to rate the company culture.